Market Snapshot

BSE Sensex: 85213.36 -0.06%
BSE 500: 37232.38 0.01%
BSE 200: 11750.56 -0.02%
BSE 100: 27239.27 -0.03%
BSE MidCap: 46552.5 0.16%
BSE SmallCap: 51096.88 0.41%
BSE BANKEX: 66710.44 0.07%
BSE IT: 37118.49 0.31%
Nifty 50: 26027.3 -0.08%
Nifty 500: 23725.2 -0.00%
Nifty 200: 14461.9 -0.05%
Nifty 100: 26555.35 -0.04%
Nifty Midcap 100: 60212.8 -0.12%
Nifty Small 100: 17425.85 0.21%
Nifty IT: 38386.25 0.29%
Nifty PSU Bank: 8285.75 0.46%

News:

Urban Company slides after sha...
Vascon Engineers gains after b...
California Software Company Lt...
Volumes jump at Nuvoco Vistas ...
SBC Exports bags Rs 11-cr manp...

Strides Pharma Science Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

Invest

15 Dec 2025 | 03:31 PM

868.80

-13.75 (-1.56%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

21.5%

Return (1Y)

Beaten Nifty 50 by 15.4%
More Volatile

3.01%

Standard Deviation (1Y)

Higher than Nifty 50 by 2.26%
Not so consistent

6/12

Months

underperformed Nifty 50
AxisDirect View

No View

52 Week High-Low

1,025

513

News & Announcements

Strides Pharma Science announces change in senior management
12 days ago

Strides Pharma Science announces change in senior management

03 - Dec - 2025 12:00 | 12 days ago

Strides Pharma Science announced that Puneet Kumar Malik, Senior Management Personnel of the Company has desired to relinquish his position w.e.f. close of business hours on 31 January 2026 to pursue other opportunity within the Aditya Birla Group.
Powered by Capital Market - Live News
Strides Pharma Science announces resignation of Group CHRO
12 days ago

Strides Pharma Science announces resignation of Group CHRO

03 - Dec - 2025 12:00 | 12 days ago

Strides Pharma Science announced that Surabhi Loshali, Group CHRO of the Company, has resigned from Strides to pursue her personal and professional aspirations. Her last working day with Strides shall be closing business hours of 02 January 2026.
Powered by Capital Market - Live News
Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter
45 days ago

Strides Pharma Science consolidated net profit rises 77.52% in the September 2025 quarter

31 - Oct - 2025 12:00 | 45 days ago

Net profit of Strides Pharma Science rose 77.52% to Rs 127.53 crore in the quarter ended September 2025 as against Rs 71.84 crore during the previous quarter ended September 2024. Sales rose 4.62% to Rs 1220.83 crore in the quarter ended September 2025 as against Rs 1166.93 crore during the previous quarter ended September 2024.

Particulars Quarter Ended
Sep. 2025 Sep. 2024 % Var.

Sales 1220.83 1166.93 5

OPM % 18.88 15.76 -

PBDT 211.53 138.53 53

PBT 161.89 90.08 80

NP 127.53 71.84 78

Powered by Capital Market - Live News
Strides Pharma soars after Q2 PAT climbs 82% YoY to Rs 131 cr
45 days ago

Strides Pharma soars after Q2 PAT climbs 82% YoY to Rs 131 cr

31 - Oct - 2025 12:00 | 45 days ago

Profit before tax (PBT) climbed 77.62% YoY to Rs 153.11 crore in Q2 FY26.
EBITDA stood at Rs 231.6 crore in Q2 FY26, registering the growth of 25.4% compared with Rs 184.6 crore in Q2 FY25. EBITDA margin improved by 320 bps to 19% in Q2 FY26 as against 15.8% in Q2 FY25.
Revenue from the US market rose 2% year-on-year to $73 million in Q2 FY26, while revenue from other regulated markets increased 16% YoY to $44 million during the quarter.
Badree Komandur, MD & Group CEO, said, ?Strides continues to deliver a strong performance in Q2FY26, with growth primarily driven by the other regulated markets. Our focus on profitability enabled the gross margin growth of 15% YoY, and EBITDA growth of 25% YoY. Operational PAT stood at Rs 140.3 crore, up 84% YoY, with EPS rising to Rs 15.2 for the quarter.
Net debt reduced sequentially by Rs 46.9 crore despite currency headwinds and ongoing capex investments, reaffirming our strong financial discipline and focus on balance sheet health. This performance demonstrates our consistent execution as we continue to invest in sustainable, long-term growth.?
Strides Pharma Science is global pharmaceutical company headquartered in Bangalore, India. It develops and manufactures wide range of niche and technically complex pharmaceutical products.
Powered by Capital Market - Live News

Price vs Volume

Stock Trivia

MF shareholding in Strides Shasun Ltd has decreased by -3.96% since past 3 Months
FII shareholding in Strides Shasun Ltd has decreased by -5.21% since past 1 Year
MF shareholding in Strides Shasun Ltd has decreased by -21.53% since past 1 Year
Promoter shareholding in Strides Shasun Ltd has increased by 7.83% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	1220.83	1166.93	5
OPM %	18.88	15.76	-
PBDT	211.53	138.53	53
PBT	161.89	90.08	80
NP	127.53	71.84	78

General Notifications

My Notifications

Research Notifications

Strides Pharma Science Ltd Share Price – NSE / BSE Pharmaceuticals, Small Cap

868.80 -13.75 (-1.56%)

News & Announcements

Price vs Volume

Stock Trivia

Strides Pharma Science Ltd Share Price – NSE / BSE
Pharmaceuticals, Small Cap

868.80

-13.75 (-1.56%)